These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34190516)

  • 1. Systemic chemotherapeutic treatment of patients with breast cancer brain metastases.
    Liubota R; Vereshchako R; Anikusko M; Liubota I; Vakulenko G
    Exp Oncol; 2021 Jun; 43(2):180-184. PubMed ID: 34190516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic disruption of the blood brain barrier in metastasis.
    Jandial R; Neman J; Chen MY
    Neurosurgery; 2014 Apr; 74(4):N11-2. PubMed ID: 24642987
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic treatments for brain metastases from breast cancer, non-small cell lung cancer, melanoma and renal cell carcinoma: an overview of the literature.
    Lombardi G; Di Stefano AL; Farina P; Zagonel V; Tabouret E
    Cancer Treat Rev; 2014 Sep; 40(8):951-9. PubMed ID: 24909312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.
    Lockman PR; Mittapalli RK; Taskar KS; Rudraraju V; Gril B; Bohn KA; Adkins CE; Roberts A; Thorsheim HR; Gaasch JA; Huang S; Palmieri D; Steeg PS; Smith QR
    Clin Cancer Res; 2010 Dec; 16(23):5664-78. PubMed ID: 20829328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trastuzumab in CNS progressive metastatic breast cancer.
    Tosoni A; Franceschi E; Esposti RD; Brandes AA
    Future Oncol; 2007 Aug; 3(4):367-9. PubMed ID: 17661709
    [No Abstract]   [Full Text] [Related]  

  • 6. A view on the landscape of breast cancer brain metastases.
    Malani R
    CNS Oncol; 2020 Sep; 9(3):CNS59. PubMed ID: 32990026
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy in breast cancer patients with brain metastases: have new chemotherapic agents changed the clinical outcome?
    Tosoni A; Franceschi E; Brandes AA
    Crit Rev Oncol Hematol; 2008 Dec; 68(3):212-21. PubMed ID: 18550383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Brain metastasis of breast tumors and blood brain barrier].
    Diéras V; Pierga JY
    Bull Cancer; 2011 Apr; 98(4):385-9. PubMed ID: 21527366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of sagopilone (ZK 219477; ZK-EPO) in patients with breast cancer and brain metastases.
    Freedman RA; Bullitt E; Sun L; Gelman R; Harris G; Ligibel JA; Krop IE; Partridge AH; Eisenberg E; Winer EP; Lin NU
    Clin Breast Cancer; 2011 Dec; 11(6):376-83. PubMed ID: 21697017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of receptor conversion on treatment efficacy and survival in breast cancer patients with brain metastases: Still debatable issue?
    Abduyev Z; Altundag K
    J BUON; 2019; 24(4):1738. PubMed ID: 31646839
    [No Abstract]   [Full Text] [Related]  

  • 11. Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer.
    Altundag K; Altundag O; Atik MA; Morandi P; Gunduz M
    Breast; 2005 Oct; 14(5):425. PubMed ID: 16216749
    [No Abstract]   [Full Text] [Related]  

  • 12. Metastases to the brain: current management perspectives.
    Nathoo N; Toms SA; Barnett GH
    Expert Rev Neurother; 2004 Jul; 4(4):633-40. PubMed ID: 15853582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of topotecan in the treatment of brain metastases.
    Wong ET; Berkenblit A
    Oncologist; 2004; 9(1):68-79. PubMed ID: 14755016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer.
    Melisko ME; Glantz M; Rugo HS
    Nat Clin Pract Oncol; 2009 Jan; 6(1):25-33. PubMed ID: 18936791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain metastases in HER2-positive breast cancer: the evolving role of lapatinib.
    Tomasello G; Bedard PL; de Azambuja E; Lossignol D; Devriendt D; Piccart-Gebhart MJ
    Crit Rev Oncol Hematol; 2010 Aug; 75(2):110-21. PubMed ID: 20004109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of T-DM1 in Her2-positive breast cancer brain metastases.
    Bartsch R; Berghoff AS; Vogl U; Rudas M; Bergen E; Dubsky P; Dieckmann K; Pinker K; Bago-Horvath Z; Galid A; Oehler L; Zielinski CC; Gnant M; Steger GG; Preusser M
    Clin Exp Metastasis; 2015 Oct; 32(7):729-37. PubMed ID: 26303828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metastases in breast cancer--an in vitro study to evaluate new systemic chemotherapeutic options.
    Honig A; Rieger L; Sutterlin A; Kapp M; Dietl J; Sutterlin MW; Kämmerer U
    Anticancer Res; 2005; 25(3A):1531-7. PubMed ID: 16033055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heading in a new direction: drug permeability in breast cancer brain metastasis.
    Sledge GW
    Clin Cancer Res; 2010 Dec; 16(23):5605-7. PubMed ID: 21045085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of patupilone in patients with brain metastases from breast cancer.
    Peereboom DM; Murphy C; Ahluwalia MS; Conlin A; Eichler A; Van Poznak C; Baar J; Elson P; Seidman AD
    Neuro Oncol; 2014 Apr; 16(4):579-83. PubMed ID: 24470546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oral tyrosine kinase inhibitors lapatinib and sunitinib: new opportunities for the treatment of brain metastases from breast cancer?
    Addeo R; Caraglia M
    Expert Rev Anticancer Ther; 2011 Feb; 11(2):139-42. PubMed ID: 21342029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.